Cash Flow Strides Pharma Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
668.00
3,675.00
-62.00
-267.00
-652.00
289.00
Adjustment
205.00
-2,884.00
818.00
682.00
582.00
363.00
Changes In working Capital
-100.00
-173.00
-78.00
-457.00
-189.00
-328.00
Cash Flow after changes in Working Capital
773.00
617.00
676.00
-43.00
-260.00
324.00
Cash Flow from Operating Activities
702.00
684.00
701.00
44.00
-257.00
481.00
Cash Flow from Investing Activities
-172.00
-90.00
-150.00
302.00
-118.00
-522.00
Cash Flow from Financing Activities
-453.00
-642.00
-693.00
-213.00
421.00
-15.00
Net Cash Inflow / Outflow
76.00
-48.00
-142.00
132.00
44.00
-56.00
Opening Cash & Cash Equivalents
112.00
161.00
303.00
170.00
125.00
182.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
188.00
112.00
161.00
303.00
170.00
125.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Strides Pharma
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
203.1
320.3
-117.00
-36.59%
Adjustment
45.56
-4.3
49.00
1159.53%
Changes In working Capital
30.48
-53.8
83.00
156.65%
Cash Flow after changes in Working Capital
279.14
262.2
17.00
6.46%
Cash Flow from Operating Activities
277.85
174.8
103.00
58.95%
Cash Flow from Investing Activities
-69.07
7.6
-76.00
-1008.82%
Cash Flow from Financing Activities
-198.93
-134.5
-64.00
-47.90%
Net Cash Inflow / Outflow
9.84
47.9
-38.00
-79.46%
Opening Cash & Cash Equivalents
6.33
326.9
-320.00
-98.06%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
16.17
374.8
-358.00
-95.69%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 2.65% vs -2.38% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
702.52
684.37
2.65%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
